tiprankstipranks
Stryker Corp (MX:SYK)
NYSE:SYK
Mexico Market

Stryker (SYK) Stock Forecast & Price Target

Followers
See the Price Targets and Ratings of:

SYK Analyst Ratings

Strong Buy
23Ratings
Strong Buy
19 Buy
4 Hold
0 Sell
Based on 23 analysts giving stock ratings to
Stryker
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SYK Stock 12 Month Forecast

Average Price Target

$6,730.69
Based on 23 Wall Street analysts offering 12 month price targets for Stryker in the last 3 months. The average price target is $6,730.69 with a high forecast of $7,944.13 and a low forecast of $5,499.78. The average price target represents a change from the last price of .
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5326":"$5,326","7945":"$7,945","5980.75":"$5,980.8","6635.5":"$6,635.5","7290.25":"$7,290.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":7944.1292021,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$8K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6730.68529101,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$7K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5499.7817552999995,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$5.50K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5326,5980.75,6635.5,7290.25,7945],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5463,5653.856092469231,5844.712184938461,6035.568277407692,6226.424369876923,6417.280462346154,6608.136554815384,6798.9926472846155,6989.8487397538465,7180.704832223077,7371.560924692308,7562.417017161539,7753.273109630769,{"y":7944.1292021,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5463,5560.514253154615,5658.028506309231,5755.542759463846,5853.057012618461,5950.571265773076,6048.085518927692,6145.599772082307,6243.114025236923,6340.6282783915385,6438.142531546154,6535.656784700769,6633.171037855384,{"y":6730.68529101,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,5463,5465.829365792308,5468.658731584615,5471.488097376923,5474.317463169231,5477.146828961539,5479.976194753846,5482.805560546153,5485.634926338461,5488.464292130769,5491.293657923076,5494.123023715384,5496.952389507692,{"y":5499.7817552999995,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7370.359,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7012.007,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7220.1,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6618.1,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6654.614,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6707.401,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6365.651,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6342.068,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6424.197,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5848.126,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5694.814,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5327.903,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5463,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$7,944Average Price Target$6,731Lowest Price Target$5,500
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on MX:SYK
Morgan Stanley
Morgan Stanley
$6,634.66$6,983.85
Buy
Upgraded
07/28/26
Analysts Are Bullish on These Healthcare Stocks: The Ensign Group (ENSG), Stryker (SYK)
Citi
$6,721.96
Buy
Reiterated
07/22/26
Citi Reaffirms Their Buy Rating on Stryker (SYK)
Bank of America Securities Analyst forecast on MX:SYK
Bank of America Securities
Bank of America Securities
$6,634.66
Buy
Reiterated
07/14/26
Analysts Offer Insights on Healthcare Companies: Shionogi & Co (Other OTC: SGIOF) and Stryker (NYSE: SYK)
RBC Capital
$7,594.94
Buy
Reiterated
07/13/26
RBC Capital Sticks to Their Buy Rating for Stryker (SYK)
BTIG
$6,617.2$6,477.52
Buy
Assigned
07/10/26
Stryker price target lowered to $371 from $379 at BTIGStryker price target lowered to $371 from $379 at BTIG
Argus Research Analyst forecast on MX:SYK
Argus Research
Argus Research
$6,110.87$6,460.06
Buy
Assigned
07/09/26
Stryker price target raised to $370 from $350 at ArgusStryker price target raised to $370 from $350 at Argus
BMO Capital Analyst forecast on MX:SYK
BMO Capital
BMO Capital
$6,442.6
Buy
Initiated
07/09/26
Analyst Initiates Buy on Stryker, Citing Resilient Fundamentals, Mako Robotics Strength and Valuation Upside Post-Cyber Incident
Wells Fargo Analyst forecast on MX:SYK
Wells Fargo
Wells Fargo
$7,298.12
Buy
Reiterated
07/08/26
Wells Fargo Remains a Buy on Stryker (SYK)
Evercore ISI Analyst forecast on MX:SYK
Evercore ISI
Evercore ISI
$6,198.17$6,110.87
Buy
Reiterated
07/06/26
Stryker price target lowered to $350 from $355 at Evercore ISIStryker price target lowered to $350 from $355 at Evercore ISI
Jefferies
$7,944.13
Buy
Reiterated
06/18/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Oncolytics Biotech (NASDAQ: ONCY), Stryker (NYSE: SYK) and Alkermes (NASDAQ: ALKS)
Truist Financial Analyst forecast on MX:SYK
Truist Financial
Truist Financial
$6,634.66$5,761.68
Hold
Reiterated
05/04/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Climb Bio (NASDAQ: CLYM), ICU Medical (NASDAQ: ICUI) and Stryker (NYSE: SYK)
William Blair Analyst forecast on MX:SYK
William Blair
William Blair
Buy
Reiterated
05/01/26
Analysts Conflicted on These Healthcare Names: Moderna (NASDAQ: MRNA) and Stryker (NYSE: SYK)
Robert W. Baird Analyst forecast on MX:SYK
Robert W. Baird
Robert W. Baird
$7,629.86$6,721.96
Buy
Reiterated
05/01/26
Stryker price target lowered to $385 from $437 at BairdStryker price target lowered to $385 from $437 at Baird
Deutsche Bank  Analyst forecast on MX:SYK
Deutsche Bank
Deutsche Bank
$7,018.77$5,499.78
Hold
Reiterated
05/01/26
Stryker price target lowered to $315 from $402 at Deutsche BankStryker price target lowered to $315 from $402 at Deutsche Bank
J.P. Morgan Analyst forecast on MX:SYK
J.P. Morgan
J.P. Morgan
$7,769.53$6,983.85
Buy
Reiterated
05/01/26
J.P. Morgan Keeps Their Buy Rating on Stryker (SYK)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on MX:SYK
Morgan Stanley
Morgan Stanley
$6,634.66$6,983.85
Buy
Upgraded
07/28/26
Analysts Are Bullish on These Healthcare Stocks: The Ensign Group (ENSG), Stryker (SYK)
Citi
$6,721.96
Buy
Reiterated
07/22/26
Citi Reaffirms Their Buy Rating on Stryker (SYK)
Bank of America Securities Analyst forecast on MX:SYK
Bank of America Securities
Bank of America Securities
$6,634.66
Buy
Reiterated
07/14/26
Analysts Offer Insights on Healthcare Companies: Shionogi & Co (Other OTC: SGIOF) and Stryker (NYSE: SYK)
RBC Capital
$7,594.94
Buy
Reiterated
07/13/26
RBC Capital Sticks to Their Buy Rating for Stryker (SYK)
BTIG
$6,617.2$6,477.52
Buy
Assigned
07/10/26
Stryker price target lowered to $371 from $379 at BTIGStryker price target lowered to $371 from $379 at BTIG
Argus Research Analyst forecast on MX:SYK
Argus Research
Argus Research
$6,110.87$6,460.06
Buy
Assigned
07/09/26
Stryker price target raised to $370 from $350 at ArgusStryker price target raised to $370 from $350 at Argus
BMO Capital Analyst forecast on MX:SYK
BMO Capital
BMO Capital
$6,442.6
Buy
Initiated
07/09/26
Analyst Initiates Buy on Stryker, Citing Resilient Fundamentals, Mako Robotics Strength and Valuation Upside Post-Cyber Incident
Wells Fargo Analyst forecast on MX:SYK
Wells Fargo
Wells Fargo
$7,298.12
Buy
Reiterated
07/08/26
Wells Fargo Remains a Buy on Stryker (SYK)
Evercore ISI Analyst forecast on MX:SYK
Evercore ISI
Evercore ISI
$6,198.17$6,110.87
Buy
Reiterated
07/06/26
Stryker price target lowered to $350 from $355 at Evercore ISIStryker price target lowered to $350 from $355 at Evercore ISI
Jefferies
$7,944.13
Buy
Reiterated
06/18/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Oncolytics Biotech (NASDAQ: ONCY), Stryker (NYSE: SYK) and Alkermes (NASDAQ: ALKS)
Truist Financial Analyst forecast on MX:SYK
Truist Financial
Truist Financial
$6,634.66$5,761.68
Hold
Reiterated
05/04/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Climb Bio (NASDAQ: CLYM), ICU Medical (NASDAQ: ICUI) and Stryker (NYSE: SYK)
William Blair Analyst forecast on MX:SYK
William Blair
William Blair
Buy
Reiterated
05/01/26
Analysts Conflicted on These Healthcare Names: Moderna (NASDAQ: MRNA) and Stryker (NYSE: SYK)
Robert W. Baird Analyst forecast on MX:SYK
Robert W. Baird
Robert W. Baird
$7,629.86$6,721.96
Buy
Reiterated
05/01/26
Stryker price target lowered to $385 from $437 at BairdStryker price target lowered to $385 from $437 at Baird
Deutsche Bank  Analyst forecast on MX:SYK
Deutsche Bank
Deutsche Bank
$7,018.77$5,499.78
Hold
Reiterated
05/01/26
Stryker price target lowered to $315 from $402 at Deutsche BankStryker price target lowered to $315 from $402 at Deutsche Bank
J.P. Morgan Analyst forecast on MX:SYK
J.P. Morgan
J.P. Morgan
$7,769.53$6,983.85
Buy
Reiterated
05/01/26
J.P. Morgan Keeps Their Buy Rating on Stryker (SYK)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BBOTBridgeBio Oncology Therapeutics
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
MLYSMineralys Therapeutics, Inc.
AMLXAmylyx Pharmaceuticals Inc
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Stryker

3 Months
Robbie MarcusJ.P. Morgan
Success Rate
14/17 ratings generated profit
82%
Average Return
+4.90%
Copying Robbie Marcus's trades and holding each position for 3 Months would result in 82.35% of your transactions generating a profit, with an average return of +4.90% per trade.
1 Year
Larry BiegelsenWells Fargo
Success Rate
21/26 ratings generated profit
81%
Average Return
+11.30%
Copying Larry Biegelsen's trades and holding each position for 1 Year would result in 80.77% of your transactions generating a profit, with an average return of +11.30% per trade.
2 Years
Jeff JohnsonRobert W. Baird
Success Rate
25/30 ratings generated profit
83%
Average Return
+19.47%
Copying Jeff Johnson's trades and holding each position for 2 Years would result in 83.33% of your transactions generating a profit, with an average return of +19.47% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SYK Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
0
0
1
1
1
Buy
37
26
37
26
27
Hold
7
5
8
6
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
44
31
46
33
32
In the current month, SYK has received 28 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. SYK average Analyst price target in the past 3 months is 6,730.69.
Each month's total comprises the sum of three months' worth of ratings.

SYK Financial Forecast

SYK Earnings Forecast

Next quarter’s earnings estimate for SYK is $60.90 with a range of $58.66 to $63.03. The previous quarter’s EPS was $45.40. SYK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 48.00% of the time in the same period. In the last calendar year SYK has Performed in-line its overall industry.
Next quarter’s earnings estimate for SYK is $60.90 with a range of $58.66 to $63.03. The previous quarter’s EPS was $45.40. SYK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 48.00% of the time in the same period. In the last calendar year SYK has Performed in-line its overall industry.

SYK Sales Forecast

Next quarter’s sales forecast for SYK is $114.87B with a range of $113.76B to $118.80B. The previous quarter’s sales results were $105.11B. SYK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 53.33% of the time in the same period. In the last calendar year SYK has Performed in-line its overall industry.
Next quarter’s sales forecast for SYK is $114.87B with a range of $113.76B to $118.80B. The previous quarter’s sales results were $105.11B. SYK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 53.33% of the time in the same period. In the last calendar year SYK has Performed in-line its overall industry.

SYK Stock Forecast FAQ

What is MX:SYK’s average 12-month price target, according to analysts?
Based on analyst ratings, Stryker Corp’s 12-month average price target is 6,730.69.
    What is MX:SYK’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for MX:SYK, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Stryker Corp a Buy, Sell or Hold?
        Stryker Corp has a consensus rating of Strong Buy, which is based on 19 buy ratings, 4 hold ratings and 0 sell ratings.
          What is Stryker Corp’s share price target?
          The average share price target for Stryker Corp is 6,730.69. This is based on 23 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $7,944.13 ,and the lowest forecast is $5,499.78. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Stryker Corp?
            Stryker Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 23 Wall Streets Analysts.
              How can I buy shares of Stryker Corp?
              To buy shares of MX:SYK, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.